List of Sproxil Champion Customers
Cambridge, 02141, MA,
United States
Since 2010, our global team of researchers has been studying Sproxil Champion customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Sproxil Champion for Customer Engagement from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Sproxil Champion for Customer Engagement include: GSK, a United Kingdom based Life Sciences organisation with 69310 employees and revenues of $42.21 billion, Bliss GVS Pharma, a India based Life Sciences organisation with 683 employees and revenues of $95.6 million, East African Cables, a Kenya based Manufacturing organisation with 500 employees and revenues of $28.0 million and many others.
Contact us if you need a completed and verified list of companies using Sproxil Champion, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Sproxil Champion customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Bliss GVS Pharma | Life Sciences | 683 | $96M | India | Sproxil | Sproxil Champion | Customer Engagement | 2011 | n/a |
In 2011, Bliss GVS Pharma engaged Sproxil's mobile authentication service leveraging Sproxil Champion for Customer Engagement to protect the anti-malarial product LONART. The public announcement described a cross-national alliance with Greenlife Nigeria and Bliss GVS Pharma that implemented consumer verification via SMS at the point of purchase.
The implementation used Sproxil Champion's customer engagement and loyalty oriented capabilities as the delivery vehicle for consumer authentication workflows, inferred from Sproxil's consumer verification platform and the vendor's later loyalty features. Functional configuration centered on SMS based two-way verification and validation of unique product codes by consumers at retail, with consumer-facing verification flows routed through Sproxil's verification service.
Operational coverage was cross-national, covering Bliss GVS Pharma markets such as India and coordinated protection activity in Nigeria through the alliance, and it targeted retail and point-of-purchase consumer touchpoints. Integrations focused on the mobile SMS channel and Sproxil's verification platform to support consumer engagement use cases and optional loyalty or rewards workflows.
Program governance aligned brand protection, commercial, and consumer engagement functions to support point-of-purchase verification workflows and consumer response handling. The case links Bliss GVS Pharma, Sproxil Champion, Customer Engagement, and consumer verification as the core components of the implementation.
|
 |
East African Cables | Manufacturing | 500 | $28M | Kenya | Sproxil | Sproxil Champion | Customer Engagement | 2013 | n/a |
In 2013, East African Cables implemented Sproxil Champion as part of the Zinduka anti counterfeit initiative, deploying a Customer Engagement platform to enable consumer verification of electrical cable products. The deployment leveraged Sproxil mobile product authentication and consumer facing verification workflows to support scratch off code validation and SMS based inquiries.
The implementation configured Sproxil Champion to issue unique scratch off codes on cable packaging, to process inbound SMS verification requests routed through Safaricom, and to log verification events into a centralized consumer verification record. Functional capabilities implemented included code validation workflows, consumer response logging for CRM use cases, and instrumentation to map verification events to geographic and distribution data, while Sproxil later bundled loyalty and consumer rewards into the Champion offering which aligns with the observed engagement pattern.
Operational scope covered East African markets and intersected sales, customer service, and brand protection functions, enabling product authentication at point of consumption. Governance emphasized verification event monitoring and channeling suspicious patterns to commercial teams for market surveillance, and the initiative helped East African Cables locate counterfeit hotspots and protect market share in the region.
|
 |
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | Sproxil | Sproxil Champion | Customer Engagement | 2011 | n/a |
In 2011, GSK implemented Sproxil Champion in Nigeria to deliver mobile product authentication at point-of-sale for the antibiotic Ampiclox. Sproxil Champion, implemented as a Customer Engagement application, operated as a consumer-facing verification platform enabling consumers to verify product authenticity and simultaneously capture market intelligence through verification transactions; the pilot recorded more than 480,000 patients sending over 600,000 verifications and identified an approximately 2.5% counterfeit alert rate.
The implementation focused on point-of-sale verification workflows and consumer verification channels that supported CRM and customer engagement use cases while feeding anonymized market intelligence into GSK field surveillance. Module usage of Sproxil Champion aligned with customer engagement and loyalty capabilities is inferred from GSK’s use of the consumer-facing verification platform and the vendor’s later rollout of loyalty features, the inference is not explicitly named in the cited pilot release. Operational scope was a pilot rollout across Nigerian points of sale for Ampiclox, and governance centered on verification transaction handling and market alerting workflows to support pharmacovigilance and anti-counterfeit efforts.
|
Buyer Intent: Companies Evaluating Sproxil Champion
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||